Table 3. Tumor Response [n = 16, 10 subjects evaluable for response having completed at least 3 cycles].
| Patient # | Cancer type | No. prior cytotoxic therapies | Cycles completed | Status | Best response |
|---|---|---|---|---|---|
| 01 | DLBC NHL | 2 | 6 cycles | Completed | CR |
| 02 | Ovarian | 5 | 6 cycles | Completed | PR |
| 03 | Ovarian | 6 | 6 cycles | Completed | CR |
| 04 | Ovarian | 6 | 1 Cycle | Neutropenia | N/A |
| 05 | Uterine | 1 | 6 cycles | Completed | PR |
| 06 | NSCLC | 2 | 6 cycles | Completed | SD |
| 07 | Ovarian | 1 | 5 Cycles | Chemo induced anemia | PR |
| 08 | Ovarian | 2 | 6 cycles | Completed | PR |
| 09 | Pancreatic | 1 | 6 cycles | Completed | SD |
| 10 | Biliary tract | 1 | 1 Cycle | PD | N/A |
| 11 | Sarcoma | 1 | 4 Cycles | Non compliance | SD |
| 12 | SLL/CLL | 2 | 3 Cycles | PD | PD |
| 13 | Breast | 6 | 6 cycles | Completed | PR |
| 14 | NSCLC | 1 | 6 cycles | Completed | SD |
| 15 | Bladder | 2 | 1 Cycle | Neutropenia | N/A |
| 16 | Ovarian | 2 | 6 cycles | Completed | CR |